Nanotherapeutics—Product Development Along the “Nanomaterial” Discussion

Journal of Pharmaceutical Sciences (Impact Factor: 2.59). 03/2014; 103(3). DOI: 10.1002/jps.23879
Source: PubMed

ABSTRACT Nanomaterials have become part of formulation development in the pharmaceutical industry and offer exciting opportunities in the area of targeted drug delivery. But they may also exert unexpected toxicities and potentially pose a threat to human health and the environment. Since the Scientific Committee on Emerging and Newly Identified Health Risks recommended a definition of “nanomaterials” for implementation into the existing and upcoming regulatory framework in the European Union, a discussion about safety requirements of new nanoscale products has emerged. At the same time, the Food and Drug Administration of the United States still observes recent developments in this area. Although the impact on the pharmaceutical product chain is still uncertain, guidelines on risk assessment in food products and cosmetics are available and offer a preview of future developments in the regimens of pharmaceuticals. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci

Download full-text


Available from: Matthias G. Wacker, Feb 07, 2014
98 Reads
  • Source
    • "The advancement of nanoscience and nanotechnology is leading to a technological revolution in human life; the advances have had a significant qualitative impact on science (Kumar S et al., 2014, Malsch, 2008, Wacker, 2014). Nanotechnology application has enormous potential to greatly influence the world in which we live. "
    [Show abstract] [Hide abstract]
    ABSTRACT: At the present time, nanotechnology is involved in every aspect of scientific life and its applications are being integrated into the economy, industry, trade and medicine. The world will require a skilled work force of more than two million nanotechnologists by 2015. The rapid advance in all fields of nanotechnology has led to integrate nanotechnology courses in high schools, institutes and university curricula all over the world. However, nanotechnology has not as, yet been integrated within the Libyan curricula at any level. Thus, this study focuses and explores the awareness of the academic staff and students in Tripoli (Alfateh) University about nanotechnology and nanoscience. Moreover their readiness to integrate the basics and applications into Libyan education curricula. The results show that education level and work place have an effect on the knowledge of the participants on nanotechnology, where about 65% of PhD degree holders knew about nanotechnology and were keen to learn and integrate this technology in the education system. Around 40 % of the participants’ information about Nanotechnology were gained from the internet while only 17% had obtained information from their own readings. The majority of the participants (60%) supported the idea of introducing nanotechnology studies to the curricula at pre-graduate stage. However, 29% believed that it should be integrated only in postgraduate studies, and only a few of the participants (11.3%) advised that a continuing education program would be the proper way to study nanotechnology. This study showed that relatively little awareness about nanotechnology is seen among Libyan staff members and students. However, the majority of the participants have realized the importance of the field of nanotechnology and its application, and were eager to learn more about this advanced technology. Based on the preliminary study regarding the opinion and readiness of participants of the current study, it is believed that the integration of nanotechnology and nanosciences in Libyan curricula at different levels of education is an inevitable step to meet the very rapid advances in the field of nanotechnology and its applications.
    Journal of Applied Pharmaceutical Science 06/2014; DOI:10.7324/JAPS.2014.40617 · 0.47 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Multivalent polymers offer a powerful opportunity to develop "theranostic" materials on the size scale of proteins that can provide targeting, imaging, and therapeutic functionality. Achieving this goal requires the presence of multiple targeting molecules, dyes, and/or drugs on the polymer scaffold. This critical review examines the synthetic, analytical, and functional challenges associated with the heterogeneity introduced by conjugation reactions as well as polymer scaffold design. First, approaches to making multivalent polymer conjugations are discussed followed by an analysis of materials that have shown particular promise biologically. Challenges in characterizing the mixed ligand distributions and the impact of these distributions on biological applications are then discussed. Where possible, molecular-level interpretations are provided for the structures that give rise to the functional ligand and molecular weight distributions present in the polymer scaffolds. Lastly, recent strategies employed for overcoming or minimizing the presence of ligand distributions are discussed. This review focuses on multivalent polymer scaffolds where average stoichiometry and/or the distribution of products have been characterized by at least one experimental technique. Key illustrative examples are provided for scaffolds that have been carried forward to in vitro and in vivo testing with significant biological results.
    Biomacromolecules 08/2014; 15(9). DOI:10.1021/bm500921q · 5.75 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Polymer nanoparticles can be prepared by self-assembling of amphiphilic polymers, and various types of molecular assemblies have been reported. In particular, in medicinal fields, utilization of these polymer nanoparticles as carriers for drug delivery system (DDS) has been actively tried, and some nanoparticulate drugs are currently under preclinical evaluations. A radionuclide is an unstable nucleus and decays with emission of radioactive rays, which can be utilized as a tracer in the diagnostic imaging systems of PET and SPECT and also in therapeutic purposes. Since polymer nanoparticles can encapsulate most of diagnostic and therapeutic agents with a proper design of amphiphilic polymers, they should be effective DDS carriers of radionuclides in the nuclear medicinal field. Indeed, nanoparticles have been recently attracting much attention as common platform carriers for diagnostic and therapeutic drugs and contribute to the development of nanotheranostics. In this paper, recent developments of solid tumor-targeting polymer nanoparticles in nuclear medicinal fields are reviewed.
    10/2014; 2014:424513. DOI:10.1155/2014/424513
Show more